A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma

BMC Cancer

Table 2 Multivariate competing risk model for LC-SM in patients with lung ASC

Characteristics	Coefficient	SHR (95% CI)	P
Age	0.008		0.15
Age’	0.003		0.62
Sex
Female	Reference	Reference
Male	0.228	1.26 (1.13–1.40)	< 0.001
Surgery
No
Yes	−0.798	0.45 (0.39–0.52)	< 0.001
T stage
T1	Reference	Reference
T2	0.416	1.52 (1.30–1.77)	< 0.001
T3	0.817	2.26 (1.82–2.81)	< 0.001
T4	0.783	2.19 (1.82–2.63)	< 0.001
N stage
N0	Reference	Reference
N1	0.398	1.49 (1.26–1.76)	< 0.001
N2	0.5	1.65 (1.43–1.90)	< 0.001
N3	0.469	1.60 (1.28–2.00)	< 0.001
M stage
M0	Reference	Reference
M1	0.477	1.61 (1.40–1.86)	< 0.001

Abbreviations: ASC adenosquamous carcinoma, CI confidence interval, LC-SM lung cancer-specific mortality, SHR subdistribution hazard ratio

ISSN: 1471-2407